FD
Frederick W Driscoll
Director

Frederick W Driscoll insider trades: Cellectar Biosciences (CLRB) stock buys and sales

Director, Cellectar Biosciences Last trade Sep 3, 2021 69 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2007
11
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Frederick reports to the SEC

and 5 more companies

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 3, 2021CLRB↑ Buy$20K
Feb 23, 2021MEIP↓ Sell$101K
Aug 11, 2020NK↓ Sell$668K
Dec 19, 2019MEIP↑ Buy$100K
Mar 23, 2017FLXN↓ Sell$69K
Feb 28, 2017FLXN↓ Sell$668K
May 17, 2016FLXN↑ Buy$25K
May 16, 2016FLXN↑ Buy$23K
Aug 9, 2011NVAX↑ Buy$24K
Nov 28, 2007GNLB↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CLRB insiders

Open-market trades in the last 12 months

About Frederick W Driscoll's insider trades

Frederick W Driscoll is a director at Cellectar Biosciences (CLRB). Since Nov 28, 2007, Frederick has reported 6 open-market purchases worth $201K and 4 sales worth $1.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (51 filings), other transactions (7 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLRB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.